Terbutaline Sulfate in Adults With Asthma

Summary

The overall aim in Part 1 is to compare the pharmacokinetic (PK)/pharmacodynamics (PD) relationship in intravenous (IV) versus subcutaneous (SQ) terbutaline sulfate to identify the optimal IV dosing range for use in Part 2. The overall aim in Part 2 is to evaluate the optimal IV dosing of terbutaline sulfate based on PD response and safety data.

Timeline

Start

2023-07-07

Primary completion

2026-12

Completion

2026-12

Outcome

Outcome not reported

Stopped (Enrollment): “The TBS02 study was paused indefinitely. No subjects were enrolled or treated, and the study may resume if circumstances change.”

Drugs

Indications